NVCT EPS Estimates
Nuvectis Pharma, Inc.
$19.02
+$1.02(+5.67%)
34
Overall
40
Value
30
Tech
34
Quality
Market Cap
$587.05M
Volume
54.24K
52W Range
$5.55 - $29.28
Target Price
$35.50
NVCT EPS estimates: the consensus estimate for Nuvectis Pharma, Inc.'s current fiscal year is -$1.01 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NVCT EPS Estimates
- EPS estimate, current quarter
- $-0.22
- EPS estimate, next quarter
- $-0.23
- EPS estimate, current year
- $-1.01
- EPS estimate, next year
- $-1.10
- EPS growth, 3-year
- +4.38%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.32 |
| 2024 | $-1.11 |
| 2023 | $-1.43 |
| 2022 | $-1.51 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVCT | $19.02 | +5.7% | 54.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |